Essa Pharma Inc EPIX

NAS: EPIX | ISIN: CA29668H7085   30/04/2025
1,820 USD (+2,82%)
(+2,82%)   30/04/2025

25 maart 2025 · ESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX · Persbericht

21 maart 2025 · Faruqi & Faruqi Reminds ESSA Pharma Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX · Persbericht

21 maart 2025 · Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in ESSA Pharma Inc. Lawsuit - EPIX · Persbericht

18 maart 2025 · Investors in ESSA Pharma Inc. Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights - EPIX · Persbericht

12 maart 2025 · Levi & Korsinsky Notifies ESSA Pharma Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - EPIX · Persbericht

7 maart 2025 · ESSA Pharma Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights - EPIX · Persbericht

6 maart 2025 · Essa Pharma Inc. Reports Results Of Annual General Meeting Of Shareholders · Persbericht

5 maart 2025 · SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma · Persbericht

4 maart 2025 · Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in ESSA Pharma Inc. Lawsuit - EPIX · Persbericht

11 september 2024 · ESSA Pharma to Present at the 2024 Cantor Global Healthcare Conference · Persbericht

5 augustus 2024 · ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2024 · Persbericht

8 juli 2024 · ESSA Pharma to Present at the JonesHealthcare Seaside Summit · Persbericht

30 mei 2024 · ESSA Pharma to Present at the Jefferies Global Healthcare Conference · Persbericht

14 mei 2024 · ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024 · Persbericht

9 april 2024 · ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference · Persbericht

8 maart 2024 · Essa Pharma Inc. Reports Results Of Annual General Meeting Of Shareholders · Persbericht

13 februari 2024 · ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023 · Persbericht

6 februari 2024 · ESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference · Persbericht

25 januari 2024 · ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium · Persbericht

12 december 2023 · ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2023 · Persbericht

Mijn selecties